Novel frameshift mutation in LIS1 gene is a probable cause of lissencephaly: a case report.
Case report
Lissencephaly
Novel mutation
PAFAH1B1
Rare disease
Whole-genome sequencing
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
received:
01
01
2022
accepted:
02
09
2022
entrez:
13
9
2022
pubmed:
14
9
2022
medline:
16
9
2022
Statut:
epublish
Résumé
Lissencephaly (LIS) is a cortical malformation, characterized by smooth or nearly smooth cerebral surface and a shortage of gyral and sulcal development, which is caused by deficient neuronal migration during embryogenesis. Neuronal migration involves many gene products, among which is the product of the PAFAH1B1 gene, associated with this disease. LIS is a rare disease, characterized by low population frequency, and with non-specific clinical symptoms such as early epilepsy, developmental delay or cerebral palsy-like motor problems. Given that high-throughput sequencing techniques have been improving diagnosis, we have chosen this technique for addressing this patient. We present the case of a seven years old male patient with an undiagnosed rare disease, with non-specific clinical symptoms possibly compatible with lissencephaly. The patient was enrolled in a study that included the sequencing of his whole genome. Sequence data was analyzed following a bioinformatic pipeline. The variants obtained were annotated and then subjected to different filters for prioritization. Also mitochondrial genome was analyzed. A novel candidate frameshift insertion in known PAFAH1B1 gene was found, explaining the index case phenotype. The assessment through in silico tools reported that it causes nonsense mediated mechanisms and that it is damaging with high confidence scores. The insertion causes a change in the reading frame, and produces a premature stop codon, severely affecting the protein function and probably the silencing of one allele. The healthy mother did not carry the mutation, and the unaffected father was not available for analysis. Through this work we found a novel de novo mutation in LIS1/PAFAH1B1 gene, as a likely cause of a rare disease in a young boy with non-specific clinical symptoms. The mutation found correlates with the phenotype studied since the loss of function in the gene product has already been described in this condition. Since there are no other variants in the PAFAH1B1 gene with low population frequency and due to family history, a de novo disease mechanism is proposed.
Sections du résumé
BACKGROUND
Lissencephaly (LIS) is a cortical malformation, characterized by smooth or nearly smooth cerebral surface and a shortage of gyral and sulcal development, which is caused by deficient neuronal migration during embryogenesis. Neuronal migration involves many gene products, among which is the product of the PAFAH1B1 gene, associated with this disease. LIS is a rare disease, characterized by low population frequency, and with non-specific clinical symptoms such as early epilepsy, developmental delay or cerebral palsy-like motor problems. Given that high-throughput sequencing techniques have been improving diagnosis, we have chosen this technique for addressing this patient.
CASE PRESENTATION
We present the case of a seven years old male patient with an undiagnosed rare disease, with non-specific clinical symptoms possibly compatible with lissencephaly. The patient was enrolled in a study that included the sequencing of his whole genome. Sequence data was analyzed following a bioinformatic pipeline. The variants obtained were annotated and then subjected to different filters for prioritization. Also mitochondrial genome was analyzed. A novel candidate frameshift insertion in known PAFAH1B1 gene was found, explaining the index case phenotype. The assessment through in silico tools reported that it causes nonsense mediated mechanisms and that it is damaging with high confidence scores. The insertion causes a change in the reading frame, and produces a premature stop codon, severely affecting the protein function and probably the silencing of one allele. The healthy mother did not carry the mutation, and the unaffected father was not available for analysis.
CONCLUSIONS
Through this work we found a novel de novo mutation in LIS1/PAFAH1B1 gene, as a likely cause of a rare disease in a young boy with non-specific clinical symptoms. The mutation found correlates with the phenotype studied since the loss of function in the gene product has already been described in this condition. Since there are no other variants in the PAFAH1B1 gene with low population frequency and due to family history, a de novo disease mechanism is proposed.
Identifiants
pubmed: 36100855
doi: 10.1186/s12887-022-03595-6
pii: 10.1186/s12887-022-03595-6
pmc: PMC9472359
doi:
Substances chimiques
Microtubule-Associated Proteins
0
1-Alkyl-2-acetylglycerophosphocholine Esterase
EC 3.1.1.47
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
545Informations de copyright
© 2022. The Author(s).
Références
Cell. 1998 Jan 9;92(1):63-72
pubmed: 9489700
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
pubmed: 12824425
Neuron. 2014 Dec 17;84(6):1226-39
pubmed: 25521378
Neuron. 2020 Apr 22;106(2):237-245.e8
pubmed: 32097630
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Birth Defects Orig Artic Ser. 1987;23(1):225-41
pubmed: 3472611
Nat Genet. 2000 Sep;26(1):93-6
pubmed: 10973257
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Am J Med Genet A. 2017 Jun;173(6):1473-1488
pubmed: 28440899
Genome Res. 2005 Jul;15(7):901-13
pubmed: 15965027
Hum Genet. 2015 Mar;134(3):305-14
pubmed: 25560765
Nature. 1994 Jul 21;370(6486):216-8
pubmed: 8028668
Am J Hum Genet. 2013 Mar 7;92(3):468-74
pubmed: 23472759
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Neuron. 2004 Dec 2;44(5):809-21
pubmed: 15572112
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Nature. 1993 Aug 19;364(6439):717-21
pubmed: 8355785
Hum Mol Genet. 2000 Dec 12;9(20):3019-28
pubmed: 11115846
Hum Mutat. 2018 Nov;39(11):1517-1524
pubmed: 30192042
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Lipid Mediat Cell Signal. 1996 Sep;14(1-3):99-102
pubmed: 8906551
Bioinformatics. 2020 Mar 1;36(6):1765-1771
pubmed: 31697312
Am J Hum Genet. 2011 May 13;88(5):536-47
pubmed: 21529751
Am J Hum Genet. 2016 Nov 3;99(5):1181-1189
pubmed: 27773428
Hum Mutat. 2007 Nov;28(11):1055-64
pubmed: 17584854
Am J Hum Genet. 2018 Dec 6;103(6):1009-1021
pubmed: 30471716
Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R89-96
pubmed: 12668601
Hum Mutat. 2002 Jan;19(1):4-15
pubmed: 11754098